Stockscreener 앱 받기
6.18
13.19%
0.72
시간 외 거래:
6.50
0.32
+5.18%
전일 마감가:
$5.46
열려 있는:
$5.54
하루 거래량:
492.67K
Relative Volume:
1.55
시가총액:
$289.49M
수익:
$12.60M
순이익/손실:
$-23.72M
주가수익비율:
-12.14
EPS:
-0.5092
순현금흐름:
-
1주 성능:
+15.30%
1개월 성능:
+33.19%
6개월 성능:
+30.38%
1년 성능:
+0.00%
1일 변동 폭
$5.36
$6.18
1주일 범위
$5.055
$6.87
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.18 | 255.76M | 12.60M | -23.72M | 0 | -0.5092 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
What Is CapsoVision's Roadmap For Growth And Innovation In 2026? - RTTNews
CapsoVision Inc Trading Resumes - MSN
CapsoVision, Inc. Announces Amendment to Sample Purchase Agreement with Canon Inc. for CMOS Image Sensor Development 5 - Minichart
CapsoVision increases development fee in amended agreement with Canon - Investing.com
CapsoVision Amends Canon Agreement for Upgraded Image Sensors - TipRanks
CapsoVision (NASDAQ: CV) adds $1M to Canon CMOS sensor deal - Stock Titan
Analyzing CapsoVision (CV) and Its Peers - Defense World
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 - Bitget
Electronic Pill Market Is Going to Boom Rapidly | Medtronic plc, CapsoVision Inc., IntroMedic Co. Ltd. - openPR.com
CapsoVision to Participate in the 38th Annual ROTH Conference - Bitget
CapsoVision CEO to field investor questions at 38th ROTH Conference - Stock Titan
Critical Analysis: CapsoVision (CV) and Its Competitors - Defense World
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
Reviewing CapsoVision (CV) and Its Rivals - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update - Defense World
CapsoVision (CV) & Its Competitors Critical Contrast - Defense World
Critical Survey: CapsoVision (CV) versus Its Rivals - Defense World
CapsoVision (CV) and Its Competitors Head-To-Head Review - Defense World
CapsoVision (CV) & Its Competitors Head to Head Survey - Defense World
Financial Review: CapsoVision (CV) & Its Peers - Defense World
Head-To-Head Contrast: CapsoVision (CV) versus Its Competitors - Defense World
Critical Contrast: CapsoVision (CV) versus Its Rivals - Defense World
Head-To-Head Comparison: CapsoVision (CV) versus The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
CapsoVision (CV) vs. Its Competitors Financial Analysis - Defense World
Reviewing CapsoVision (CV) & Its Competitors - Defense World
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Contrast: CapsoVision (CV) & Its Competitors - Defense World
Contrasting CapsoVision (CV) and The Competition - Defense World
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Reviewing Perspective Therapeutics (NASDAQ:CATX) & CapsoVision (NASDAQ:CV) - Defense World
CapsoVision seeks FDA clearance for AI endoscopy module - MSN
Insider-Owned Growth Stocks Poised For Success In January 2026 - simplywall.st
CapsoVision (CV) Price Target Increased by 75.00% to 10.71 - Nasdaq
CapsoVision (NASDAQ:CV) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CapsoVision Submits 510(k) Application for CapsoCam AI-Assisted Module - Medical Product Outsourcing
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Barchart.com
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
Capsovision Inc (CV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):